Work

The PARAGON-Heart failure trial – another disappointment for heart failure patients with hypertension and preserved ejection fraction

Year: 2019

Type: editorial

Abstract: Novel angiotensin receptor antagonist/neprilysin inhibitors (ARNIs) seek to exploit the clinical benefits of combining renin-angiotensin-aldosterone-system (RAAS) antagonism and neutral endopeptida...

Source: Blood Pressure

DOI: 10.1080/08037051.2019.1664717

Authors: Sverre E. Kjeldsen, Krzysztof Narkiewicz, Michel Burnier, Suzanne Oparil

Institutions: University of Oslo, Gdańsk Medical University, Centre Hospitalier Universitaire Vaudois, University of Alabama at Birmingham, UAB Medicine

Language: English

Topic: Heart Failure Treatment and Management

Subfield: Cardiology and Cardiovascular Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: bronze

OpenAlex ID: W2975933595

Cites: 20

Cited by:

Related to: 10